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INTRODUCTION 
Obesity is a chronic and increasingly common health hazard 
characterized by excess body fat. It develops gradually and often persists 
throughout life. As a preventable cause of death in the US, obesity is 
second only to smoking.  
 
Traditionally, obesity was believed to be associated with affluent 
lifestyles in the West countries. However, obesity is a fast growing 
problem in developing countries and is now known to be associated with 
increased health risks. Several studies in India have shown that changes 
in dietary patterns, physical activity levels, life styles associated with 
affluence and migration to urban areas are related to increasing risk of 
metabolic diseases such as type 2 diabetes mellitus, hypertension and 
dyslipidemia. 
 
  The most widely used method to gauge obesity is the  Body mass 
index (BMI) and it focus in obesity treatment recommendations, with 
different treatment cutoff points based up on the presence or absence of 
obesity-related comorbid disease. In addition, many patients with these 
metabolic diseases are either overweight or obese.  Important relationship 
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between BMI and metabolic disease is critical toward a better 
understanding of the underlying pathophysiological processes leading to 
excessive fat-related metabolic disease. 
 
This study   brings out the important risk factors for cardiovascular 
disease like hypertension and dyslipidemia in obese patients correlated 
with various BMI levels. 
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REVIEW OF LITERATURE 
 
OBESITY 
Prevalence of Obesity  
 The worldwide prevalence of obesity has increased dramatically 
over the last several decades. In the United States alone, about one third 
of adults aged 20 to 74 years are considered obese.[1] According to 
national population surveys conducted since 1960, the prevalence of 
obesity (BMI >30 kg/m2) has more than doubled from 13% to 32% [1] [2]; 
the prevalence of obesity increases progressively from 20 to 50 years of 
age, but it then declines after 60 to 70 years of age.  
 The prevalence of obesity has also risen in children and 
adolescents. As defined by a BMI greater than the 95th percentile for age 
and gender from the revised National Center for Health Statistics growth 
charts, 17% of 6- to 17-year-old children and adolescents in the United 
States are overweight [1] [3]. These data indicate that overweight 
prevalence rates for children and adolescents, reported by earlier surveys, 
have doubled. Diseases commonly associated with obesity in adults, such 
as type 2 diabetes mellitus, hypertension, hyperlipidemia, gallbladder 
disease, nonalcoholic steatohepatitis (NASH), sleep apnea, and 
orthopedic complications, are now increasingly observed in children. 
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INDIAN SCENARIO  
Obesity is emerging as an important problem in India. Twenty two 
million Indians are obese, especially abdominally obese. The Nutrition 
Foundation of India (NFI) study showed that 32.3% of middle class males 
and 50% of middle class females in Delhi are obese4. 
Prevalence pattern of obesity across different age groups  studied  
rural setting in Kerala  included  3423 subjects over 20 years of age 
showed 30-40 % of the population in their study setting was either obese 
or overweight5. 
 Prevalence of obesity in adults--an epidemiological study from 
Kashmir Valley of India   showed that  according to BMI, the overall 
prevalence of obesity in the study population was 15.01%;   The 
prevalence of obesity in males was 7.01% and in females 23.69%6. 
   Prevalence of overweight in urban Indian adolescent school 
children study showed that Age-adjusted prevalence of overweight was 
17.8% for boys and 15.8% for girls7.  
Definition of Obesity 
 Obesity is a state of excess adipose tissue mass. Although often 
viewed as equivalent to increased body weight, this need not be the case -
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-lean but very muscular individuals may be overweight by arbitrary 
standards without having increased adiposity.8  
Assessing Obesity 
Visual inspection of a patient can give a subjective but fairly 
accurate estimate of the degree of obesity. Obesity is usually easily 
diagnosed using what has been called the eyeball test. ‘If a person looks 
fat, the person is fat.’ 
Presently, there are three commonly used objective methods of 
estimating obesity in clinical practice: body mass index, waist-to-hip ratio 
and waist circumference and fat distribution4. 
 
Body Mass Index 
The most widely used method to gauge obesity is the Body Mass 
Index. (Also called Quetelet Index) 
Body Mass Index (BMI) = weight/height2 (in kg/m2)  
Most authorities use the term overweight (rather than obese) to 
describe individuals with BMIs between 25 and 30. A BMI between 25 
and 30 should be viewed as medically significant and worthy of 
therapeutic intervention, especially in the presence of risk factors that are 
influenced by adiposity, such as hypertension and glucose intolerance. 
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 Large epidemiologic studies9,10 established an inverse relationship 
between BMI and mortality above BMI values of 25.0 kg/m2. Men and 
women with a BMI between 25.0 and 29.9 kg/m2 are considered 
overweight, and those with a BMI greater than 30.0 kg/m2 are considered 
obese. Obese persons are at higher risk for adverse health consequences 
than those who are overweight. These criteria for overweight and obesity 
represent imposed cutoff values along a continuum between mortality 
rate and BMI. 
Classification of Weight Status and Risk of Disease8  
Table :1 
  BMI (kg/m2) Obesity Class Risk of Disease 
Underweight <18.5     
Healthy weight 18.5–24.9     
Overweight 25.0–29.9   Increased 
Obesity 30.0–34.9 I High 
Obesity 35.0–39.9 II Very high 
Extreme Obesity ≥ 40 III Extremely high 
 
Source: Adapted from National Institutes of Health, National Heart, 
Lung, and Blood Institute: Clinical Guidelines on the Identification, 
7 
 
Evaluation, and Treatment of Overweight and Obesity in Adults. U.S. 
Department of Health and Human Services, Public Health Service, 1998. 
 
 
The BMI for native Asian Indians 4 
Table :2 
Classification of Overweight and obesity by Body mass index (BMI) 
for Indians 
                                           Obesity Class BMI(kg/m2) 
Under weight  <18.5 
Normal  18.5-22.9 
Overweight  23.0-27.9 
Obesity I 28.0-32.9 
 II 33.0-37.9 
Extreme obesity III ≥38 
Waist-to-Hip Ratio (WHR) and Waist Circumference 
The waist-to-hip ratio provides information about the distribution 
of body fat 
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Body Fat Distribution (Fat Phenotypes) 
On the basis of distribution of body fat, obesity may be classified 
in to android obesity and gynoid obesity. 
Apple type and pear shaped obesity  
 On the basis of body fat distribution, obesity may be classified into 
android and gynoid types. 
 Android obesity is the collection of fat mostly in the abdomen 
(above the waist). It is also called central obesity and is associated with 
an increased risk of metabolic complications such as CAD, DM, HT and 
dyslipidemia. It is the most common acquired cause of insulin resistance. 
Also known as apple type body. 
 Gynoid obesity (pear shaped body) is the collections of fat on the 
hips and buttock (below the waist or gluteo femoral). This makes the 
person more prone to mechanical disorders such as varicose vein and 
disorders of the joints. 
 
Measurement of central obesity 
Waist hip ratio (WHR) 
 The usual measure of central obesity is waist hip ratio. Since the 
excess fat is usually concentrated in the hip in women and the waist in 
men, the optimum value for the waist hip ratio is lower in women(<0.85) 
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than in men (<0.95). The desired waist to hip ratio in men is ≤ 1.0 and in 
women is ≤ 0.84.  
Waist hip ratio > 1.0 in men and >0.9 in women is abnormal 
(Harrison p.463) and is associated with high morbidity and mortality.  
 
Waist circumference 
 Recently waist circumference has been found to be even better 
market of central obesity than waist hip ratio. For Asian Indians the 
optimum waist circumference is <80cm in women and <90cm in men11.  
In men there is increased risk if the waist circumference is 85cm or 
more and substantial risk if it is 90cm or more. For women the figures are 
≥ 80 and ≥ 85cms respectively4.                    
Many of the most important complications of obesity, such as 
insulin resistance, diabetes, hypertension, hyperlipidemia, and hyper 
androgenism in women, are linked more strongly to intra abdominal 
and/or upper body fat than to overall adiposity .The mechanism 
underlying this association is unknown but may relate to the fact that intra 
abdominal adipocytes are more lipolytically active than those from other 
depots. Release of free fatty acids into the portal circulation has adverse 
metabolic actions, especially on the liver.  
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 BMI-associated health risk is also influenced by ethnicity12, the 
risk of diabetes is higher in Southeast Asian populations than in whites. 
 Another factor that modifies the risk of obesity-related 
complications is weight gain during adulthood. In both men and women, 
weight gain of 5 kg or more since the ages of 18 to 20 years increases the 
risk of developing diabetes, hypertension, and coronary heart disease, and 
the risk of disease increases with the amount of weight gained 13,14,15,16.  
 
Etiology of Obesity  
Energy Balance  
 Obesity is caused by an excessive intake of calories in relation to 
energy expenditure over a long period of time. Large increases in body 
fat can result from even minor, but chronic, differences between energy 
intake and energy expenditure. In 1 year, the ingestion of only 5% more 
calories than expended can promote the gain of approximately 5 kg in 
adipose tissue. Over 30 years, the ingestion of only 8 kcal /day more than 
expended can increase body weight by 10 kg17. 
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 Genes and Environment  
 Body size depends on the complex interaction between genetic 
background and environmental factors. In humans, genetic background 
explains only an estimated 40% of the variance in body mass.18 
 
SOME REASONS FOR THE INCREASING PREVALENCE OF 
OBESITY – THE ‘OBESOGENIC’ ENVIRONMENT19 
Increasing energy intake Decreasing energy expenditure 
1. Increasing portion sizes 
2. Increasing snacking and 
loss of regular meals 
3. Increasing energy-dense 
food (mainly fat) 
4. Increasing affluence 
 
1. Increasing car ownership 
2. Decreasing walking to 
school/work 
3. Increasing automation; 
decreasing manual labour. 
4. Decreasing sports in 
schools 
5. Increasing time spent on 
video games and 
watching TV 
6. Increasing Central heating
12 
 
Influences of Childhood and Parental Obesity  
 The risk of becoming an obese adult is influenced both by having 
been obese as a child and by having had at least one obese parent..The 
risk of being obese at 21 to 29 years of age ranged from 8% for persons 
who were obese at 1 to 2 years of age and had nonobese parents to 79% 
for persons who were obese at 10 to 14 years of age and had at least one 
obese parent.20 
Obesity Genes in Humans 
Table:3 
Gene Gene Product Mechanism of Obesity 
Lep 
(ob)  
Leptin, a fat-derived 
hormone 
Mutation prevents leptin from 
delivering satiety signal; brain 
perceives starvation 
LepR 
(db)  
Leptin receptor Same as above 
POMC Proopiomelanocortin, a 
precursor of several 
hormones and 
neuropeptides 
Mutation prevents synthesis of 
melanocyte-stimulating hormone 
(MSH), a satiety signal 
MC4R  Type 4 receptor for MSH Mutation prevents reception of 
satiety signal from MSH 
PC-1 Prohormone convertase 
1, a processing enzyme 
Mutation prevents synthesis of 
neuropeptide, probably MSH 
TrkB  TrkB, a neurotrophin 
receptor 
Hyperphagia due to 
uncharacterized hypothalamic 
defect 
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Syndromes associated with of Obesity 8 
1. Prader-Willi syndrome 
2. Laurence-Moon-Biedl syndrome 
3. Ahlstrom syndrome 
4. Cohen syndrome 
5. Carpenter syndrome 
POTENTIALLY REVERSIBLE CAUSES OF WEIGHT GAIN19 
Endocrine factors Drug treatments 
Hypothyroidism 
Hypothalamic tumours or injury 
Cushing’s syndrome 
Insulinoma 
 
Tricyclic antidepressants 
Corticosteroids 
Sulphonylureas 
Oestrogen-containing contraceptive 
pill 
Corticosteroids 
Sodium valproate 
β- Blockers 
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Pathogenesis of Obesity 
Energy Metabolism  
The components of daily total energy expenditure (TEE) are 
resting energy expenditure (REE), which accounts for approximately 
70% of TEE; energy expended in physical activity, which accounts for 
approximately 20% of TEE; and the thermic effect of food (TEF), which 
accounts for approximately 10% of TEE. REE represents the energy 
expended for normal cellular and organ function under post absorptive 
resting conditions. 
Evidence from studies in obese and lean subjects, matched for 
either fat mass or lean body mass, suggests that obese subjects have a 
small (75 kcal/day) but potentially important reduction in TEF. This 
reduction in TEF might arise from the insulin resistance and blunted 
sympathetic nervous system activity that occur in obesity.[53] 
Obesity causes many serious medical complications that impair 
quality of life and lead to increased morbidity and premature death21 
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Clinical Features and Complications of Obesity  
Endocrine and Metabolic Diseases  
The Metabolic or Insulin-Resistance Syndrome  
Type 2 Diabetes Mellitus 
 
Dyslipidemia  
Cardiovascular Disease  
Hypertension  
Coronary Heart Disease  
 
Cerebrovascular and Thromboembolic Disease  
Pulmonary Disease  
Restrictive Lung Disease  
Obesity-Hypoventilation Syndrome  
 
 Obstructive Sleep Apnea  
Musculoskeletal Disease  
Gout  
Osteoarthritis  
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Cancer  
In both men and women, BMI was also significantly associated 
with higher rates of death due to cancers of the esophagus, colon and 
rectum, liver, gallbladder, pancreas, and kidney; non-Hodgkin's 
lymphoma; and multiple myeloma. Significant trends of increasing risk 
with higher BMI values were observed for death from cancers of the 
stomach and prostate in men and for death from cancers of the breast, 
uterus, cervix, and ovary in women.22 
 
Genitourinary Disease in Women  
Neurologic Disease  
Obesity increases the incidence of ischemic stroke.  
          Obesity is also associated with idiopathic intracranial hypertension 
(IIH), also known as pseudo tumor cerebri. 
 
Cataracts  
Gastrointestinal Disease  
Gastro esophageal Reflux Disease  
Gallstones 
 Pancreatitis 
 Liver Disease  
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Obesity is associated with a spectrum of liver abnormalities, which 
are now referred to as nonalcoholic steatohepatitis.23 
Metabolic or insulin-resistance syndrome, also known as syndrome X, 
the specific phenotype of upper-body, or abdominal, obesity is associated 
with a cluster of metabolic risk factors for coronary heart disease (CHD).  
Features of this syndrome include 
¾ Insulin resistance with associated hyperinsulinemia 
¾ Impaired glucose tolerance, impaired insulin-mediated glucose 
disposal, and type 2 diabetes mellitus; 
¾ Dyslipidemia, characterized by hypertriglyceridemia and low 
serum HDL-cholesterol levels and Hypertension. 
 Other metabolic risk factors, including 
¾ Increased serum levels of apolipoprotein B;  
¾ Small, dense LDL particles; and  
¾ Plasminogen activator inhibitor 1 (PAI-1) with impaired 
fibrinolysis have also been associated with abdominal obesity. 
(24)(25) 
There is increasing evidence that the ectopic distribution of 
triglycerides in nonadipose tissue may be involved in the complications 
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of obesity. In cross-sectional studies, insulin resistance was highly 
correlated with the intramyocellular concentration of triglyceride.26 
DIAGNOSTIC CRITERIA FOR METABOLIC SYNDROME 
Table:4 
Clinical measure WHO (1998) ATP III (2001) 
Insulin resistance IGT, IFG or lowered insulin 
sensitivity plus any two of 
the following 
None, but any 3 of the 
following 5 features 
Body weight Men: WHR > 0.90 
Women : WHR > 0.85 
And / or BMI > 30kg/m2 
WC ≥102 cm in men or  
≥ 88 cm in women 
Lipid TG >150 mg/dL and /or 
HDL-C < 35mg/dL in men  
or < 39mg/dL in women 
TG >150mg/dL HDL-
C < 40mg/dL in men or 
< 50mg/dL in women 
Blood pressure > 140/90 mmHg ≥ 130/85 mmHg 
Glucose IGT, IFG or T2DM > 110 mg/dL (includes 
diabetes) 
Microabluminuria Urine albumin excretion 
rate: 20 mcg per minute 
Other features of 
insulin resistance 
The criteria by WHO and ATP III for diagnosing metabolic 
syndrome may not be appropriate for Asians. IDF (International diabetes 
federation) had made a first attempt to provide ethnic group specific cut 
off points for some risk factor such as waist circumference. 
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IDF criteria for metabolic syndrome 
 Increased waist circumference (population specific) plus any 2 of 
the following: 
• TGL ≥ 150mg/dL or on specific treatment for TGL 
• HDL < 40mg/dL in men or < 50mg/dL in women or on 
treatment for this lipid abnormality. 
• BP ≥ 139mm of Hg systolic or ≥ 85mm of Hg diastolic or on 
antihypertensive treatment. 
• Fasting plasma glucose ≥ 100mg/dL (includes diabetes).  
Type 2 Diabetes Mellitus in Obesity 
The marked increase in the prevalence of obesity has played an 
important role in the 25% increase in the prevalence of diabetes that has 
occurred in the United States over the last 20 years(27).According to data 
from NHANES III, two thirds of the men and women in the United States 
with diagnosed type 2 diabetes have a BMI of 27.0 kg/m2 or 
greater.(28).The risk of diabetes increases linearly with BMI: the 
prevalence of diabetes increased from 2% in those with a BMI of 25.0 to 
29.9 kg/m2, to 8% in those with a BMI of 30 to 34.9 kg/m2, and to 13% in 
those with a BMI greater than 35 kg/m2. 
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In the Nurses' Health Study, the risk of diabetes began to increase 
when BMI exceeded the “normal” value of 22 kg/m2. (27) 
The risk of diabetes also increases with weight gain during 
adulthood.29,30,31. Among men and women aged 35 to 60 years, the risk of 
diabetes was three times greater in those who gained 5 to 10 kg since the 
age of 18 to 20 years than in those who maintained their weight within 2 
kg. 
Dyslipidemia in Obesity 
Obesity is associated with several serum lipid abnormalities 
including hypertriglyceridemia, reduced HDL cholesterol levels, and an 
increased fraction of small, dense LDL particles. 32 This association is 
especially strong in persons with abdominal obesity. In addition, most 
studies suggest that serum concentrations of total and LDL cholesterol are 
elevated in obesity. Data from NHANES III showed that in men, there 
was a progressive increase in the prevalence of hypercholesterolemia 
(total blood cholesterol >240 mg dL or 6.21 mmol/L) with increasing 
BMI.33 In women, by contrast, the prevalence of hypercholesterolemia 
was highest at a BMI of 25.0 to 27.0 kg/m2, and it did not increase further 
at higher BMI values. The serum lipid abnormalities associated with 
obesity are important risk factors for CHD. . 
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Hypertension in Obesity     
There is a linear relationship between hypertension and BMI. [127] 
[128] In NHANES III, the age-adjusted prevalence of hypertension 
(defined as systolic blood pressure >140 mm Hg, diastolic blood pressure 
>90 mm Hg, or use of antihypertensive medication) in obese men and 
women was 42% and 38%, respectively. These prevalence rates are more 
than twice as high as the prevalence rates of hypertension in lean men and 
women (15% prevalence rate in both men and women)33. The risk of 
hypertension also increases with weight gain. Among subjects followed 
in the Framingham Study, there was a 6.5-mm Hg increase in blood 
pressure with every 10% increase in body weight.34  
Weight gain, even to levels not considered to be a problem, 
increases the incidence of hypertension. This was clearly shown in a 
Nurses' Health Study.35.Those women, now in midlife, who had gained as 
little as 5 kg over their weight at age 18 had a 60% higher relative risk of 
developing hypertension than did those whose weight had not changed 
more than 2 kg. Those who gained 10 kg or more had a 2.2-fold greater 
risk. In a cross-sectional study, adults with a BMI >40 had a 6.38 times 
greater odds ratio for hypertension 36 
Moreover, obesity is accompanied by an increased incidence of 
hypertension-related outcomes, including stroke 37, coronary disease 38 
heart failure 39, and restrictive cardiomyopathy 40. 
22 
 
 
Pathophysiology of hypertension in Obesity 
a. Fluid volume distribution and systemic hemodynamic changes 8 
Obese patients have a distinct cardiovascular abnormality 
characterized by increased total and central blood volumes, cardiac 
output, and left ventricular filling pressure. The elevated cardiac output 
appears to be required to support the metabolic needs of the excess 
adipose tissue. Left ventricular filling pressure is often at the upper limits 
of normal at rest and rises excessively with exercise. As a result of 
chronic volume overload, eccentric cardiac hypertrophy with cardiac 
dilatation and ventricular dysfunction may develop.. Pulmonary 
congestion, peripheral edema, and exercise intolerance may all ensue;  
b. Insulin resistance 
c. .sympathetic nervous system activity 
   Sympathetic activation appears to mediate at least part of the 
obesity-induced sodium    retention and hypertension since adrenergic 
blockade or renal denervation markedly attenuates these changes 41 
d. Sodium – potassium  ATP-ase 
e. Renin-angiotensin system (RAS) and serum   aldosterone levels  
 
f. Increased leptin from selective leptin resistance41 
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Leptin is an adipocyte-derived hormone that acts in the 
hypothalamus to regulate appetite, energy expenditure and sympathetic 
nervous system outflow. One of the major mechanisms leading to the 
development of obesity-induced hypertension appears to be leptin-
mediated sympatho-activation. Leptin adversely shifts the renal pressure–
natriuresis curve, leading to relative sodium retention. 
g. Increased free fatty acids 43 
h. Decreased nitric oxide44 
i. Increased endothelin-145 
    j. Obstructive sleep apnea (OSA)46 
Among the risk factors for OSA, obesity is probably the most 
important. Significant sleep apnea is present in 40% of obese 
individuals, and 70% of OSA patients are obese Possible mechanisms 
whereby OSA may contribute to hypertension in obese individuals 
include sympathetic activation, hyperleptinemia, insulin resistance, 
elevated angiotensin II and aldosterone levels. 
From the clinical and therapeutic perspectives, the presence of 
resistant hypertension and the absence of a nocturnal decrease in blood 
pressure in obese individuals should prompt the clinician to consider the 
diagnosis of OSA, especially if clinical symptoms suggestive of OSA 
(such as poor sleep quality, witnessed apnea, excessive daytime 
somnolence, and so forth) are also present.          
24 
 
Adipose Tissue and Triglyceride Metabolism  
Triglycerides stored within adipose tissue constitute the body's 
major energy reserve. Triglycerides are a much more compact fuel than 
glycogen because of the energy density and hydrophobic nature of fat. 
Triglycerides yield 9.3kcal/g upon oxidation and are compactly stored as 
oil inside the fat cell, accounting for 85% of adipocyte weight. Glycogen, 
in contrast, yields only 4.1kcal/g upon oxidation and is stored 
intracellularly as a gel containing approximately 2 g of water for every 1 
g of glycogen.  
Adipose tissue is an effective storage mechanism for transportable 
fuel that allows mobility and survival when food is scarce. During 
starvation, the duration of survival is determined by the size of the 
adipose tissue mass 
Triglyceride Storage  
The major function of adipocytes is the storage of triglycerides for 
future use as energy substrate. Lipogenesis from glucose makes only a 
limited contribution to triglyceride storage in the adipocyte.47 
Most of the triglyceride in adipocytes is derived from chylomicrons 
and very-low-density lipoprotein (VLDL) triglycerides that originate, 
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respectively, from dietary and hepatic sources. These plasma triglycerides 
are hydrolyzed by lipoprotein lipase (LPL), a key regulator of fat cell 
triglyceride uptake from circulating triglycerides. Lipoprotein lipase is 
synthesized by adipocytes and transported to the endoluminal surface of 
endothelial cells. The interaction of LPL with chylomicrons and VLDL 
releases fatty acids from plasma triglycerides, which are then taken up by 
local adipocytes. Plasma free fatty acids themselves can also be taken up 
by adipose tissue, independent of LPL. 
Insulin and cortisol are the principal hormones involved in 
regulation of LPL activity and expression.[48] The activity of LPL within 
individual tissues is a key factor in partitioning triglycerides among 
different body tissues. Insulin influences this partitioning through its 
stimulation of LPL activity in adipose tissue.[49] Insulin also promotes 
triglyceride storage in adipocytes through other mechanisms, including 
inhibition of lipolysis, stimulation of adipocyte differentiation, and 
escalation of glucose uptake. Cortisol's importance in fat distribution is 
supported by the clinical appearance of patients with Cushing's syndrome. 
The obesity-promoting effect of cortisol can involve a synergistic effect 
of cortisol and insulin on the induction of LPL in adipose tissue, as has 
been demonstrated in vitro. Testosterone, growth hormone, 
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catecholamines, tumor necrosis factor (TNF), and other related cytokines 
inhibit lipoprotein lipase activity.[48] 
Adipose Tissue as an Endocrine Organ  
Traditionally, adipocytes have been viewed as energy depots that 
store triglycerides during feeding and release fatty acids during fasting to 
provide fuel for other tissues. However, adipose tissue secretes numerous 
proteins that have important physiologic functions. These factors 
participate in autocrine and paracrine regulation within adipose tissue and 
can affect the functions of distant organs, such as muscle, the pancreas, 
the liver, and the central nervous system.  
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ADIPOCYTE-SECRETED PROTEINS 
Table :5 
Category Protein 
Hormone Leptin, resistin, angiotensinogen, ACRP 30, 
estrogens, visfatin 
Cytokine Interleukin-6, tumor necrosis factor-α 
Extracellular matrix 
protein 
Types I, III, IV, and VI collagen; fibronectin, 
osteonectin, laminin, entactin, MMP-2 
Complement factor Adipsin, complement C3, factor B 
Enzyme Cholester ester transfer protein, lipoprotein 
lipase 
Acute phase response 
protein 
α-1 Acid glycoprotein, haptoglobin 
Other Fatty acids, plasminogen activator inhibitor-1, 
prostacyclin 
 
Leptin  
Adipocytes produce leptin and secrete it into the bloodstream. 
Leptin has pleiotropic effects on food intake, hypothalamic 
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neuroendocrine regulation, reproductive function, and energy expenditure 
[50] [51]. There is a direct relationship between plasma leptin concentrations 
and BMI or body fat percentage 
Resistin  
Resistin is another signaling polypeptide secreted by adipocytes.[52]  
Adiponectin  
Adiponectin is the most abundant secretory protein produced by 
adipocytes. In contrast to other secretory products of adipocytes, the 
plasma concentrations of adiponectin are decreased in obesity and insulin 
resistance. There is a close association between hypoadiponectinemia, 
insulin resistance, and hyperinsulinemia.[53] Conversely, adiponectin 
expression increases with improved insulin sensitivity and weight loss.[54] 
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AIMS AND OBJECTIVES 
 
 
 
1. To study the prevalence of dyslipidemia, hypertension and  
diabetes among the obese . 
 
2. To study the  dyslipidemia in correlation with  Body Mass Index 
and compare among the different groups. 
 
3. To study about the Hypertension in correlation with Body Mass 
Index and compare  among the different groups.     
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MATERIALS AND METHODS 
 
Setting                             :   Outpatient Department and Medical  Wards,  
                                              Govt Rajaji Hospital, Madurai. 
 
Collaborating Department   :    Department of Biochemistry, 
                                                      Madurai Medical College, 
                                                      Madurai. 
 
Design of the study              :  Cross sectional study 
 
Period of the Study            :     JUNE 2007 –MAY 2008 
 
 Sample size                      :    80 patients study group and 20  
patients control group. 
 
 Ethical approval   : Obtained 
 Consent    :        Informed consent was obtained 
Financial Support           :  Nil 
Conflict of Interest     : Nil 
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SELECTION OF THE STUDY SUBJECTS AND 
CONTROLS 
Among  patients attending medical Outpatient  Department and  Medical 
Wards   in Govt Rajaji Hospital for varying illness , 80 Patients  ( 40 
Males and 40 Females )  whose BMI  were  ≥ 25  selected for  the  study 
Group(Group II ,III ,IV ) and 20 Patients ( 9 males and 11 Females)   
whose BMI  < 25  were selected   in  the same age group as controls. 
(Group I) 
 
Divided into four groups according to BMI  
        Group                BMI   
            I                    25                Healthy weight 
           II                   ≥ 25 – 26.9     Overweight 
           III                   ≥27 – 29.9     Overweight 
            IV                   ≥30               Obesity 
 
 
INCLUSION CRITERIA 
Both males and females more than 20 years of age including 
hypertension and Diabetes Mellitus. 
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EXCLUSION CRITERIA 
1. Less than 20 years of age 
2. Pregnancy. 
3. Secondary causes affecting  the lipid profile was not included                                
Nephrotic syndrome  
          Hypothyroidism 
                               Chronic renal failure 
                               Connective tissue disorder 
                                Patients on hypolipidemic drugs, diuretics, β 
blockers 
                               Patient with previous history of CAD on 
hypolipidemic drugs 
80 patients both males and females more than 20 years of age were taken 
as cases. 20 age matched males and females were taken as controls. 
 
History 
 Careful history was first taken in these patients regarding pre 
existing diabetes mellitus, systemic hypertension and dyslipidemia and 
about the treatment for these illnesses. 
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Anthropometry 
 In all these patients the following anthropometric measurements 
are done 
1. Height 
2. Weight 
3. Waist Circumference 
4. Hip Circumference 
From these measurements Body Mass Index and waist hip ratio 
were calculated. 
 
Blood pressure recording 
BP was taken three times to confirm systemic hypertension. 
 
 
Investigations 
 The following Investigations were done after a overnight fasting 
for more than 8 hours, 
1. Fasting Plasma Glucose 
2. Lipid profile 
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By history, clinical examination and biochemical analysis, 
secondary causes of elevated lipid profile was excluded. The collected 
data’s were analyses for correlation with Body Mass index. 
 
DEFINITION 
Hypertension – Patient was considered to be  hypertensive if 
patient was diagnosed earlier  or if patients was on anti hypertensive 
medication or if blood pressure during  recording  it was found to be more 
than 140mm Hg systolic or 90 mm Hg diastolic according to JNC VII 
definition. 
Diabetes – Patient was considered to be diabetic if she was diagnosed 
earlier or was on anti diabetic treatment or on admission, found to have 
fasting plasma glucose more than 126mg% according to ADA Criteria.  
Dyslipidemia  
Defined to include any one of the following: 
Total  cholesterol (TC)  240 mg/dl 
Triglycerides  (TG) > 200 mg/dl 
Low-density lipoprotein cholesterol (LDL-C)  160 mg/dl 
High-density lipoprotein cholesterol (HDL-C) < 40 mg/dl 
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Height – Height was taken by asking the patient to stand erect without 
foot wears against to the wall and the vertical height was measured in 
centimeters. 
Weight – Weight was measured in kilograms using a weighing machine. 
Body Mass Index  
It is calculated by, 
Body Mass Index (BMI) = weight/height2 (in kg/m2)  
Waist circumference – Abdominal girth at the level of equidistant 
between costal margin and iliac crest ≥ 85cm is taken as abnormal in 
women and ≥90 cm in Men. 
 
Hip circumference – Body girth at the level of greater trochanter is 
measured. 
 
Waist hip ratio – is the ratio calculated by dividing waist circumference 
by hip circumference. Value ≥ 0.85 is taken as abnormal in women and  
≥0.95 in Men.. 
 
Lipid profile consists of total cholesterol, TG, LDL, HDL and VLDL 
done direct enzymatic assay. 
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STATISTICAL ANALYSIS 
 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2002).  
 Using this software, range, frequencies, percentages, means, 
standard deviations, chi square and 'p' values were calculated. Kruskul 
Wallis chi-square test was used to test the significance of difference 
between quantitative variables and Yate’s test for qualitative variables. A 
'p' value less than 0.05 is taken to denote significant relationship. 
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RESULTS AND OBSERVATIONS  
PROFILE OF CASES STUDIED 
Table 6 : Age distribution 
Test Group Control Group 
Age group 
No % No % 
Upto 30 yrs 13 16.3 4 20 
31-40 21 26.3 5 25 
41-50 19 23.8 5 25 
51-60 12 15 5 25 
Above 60 15 18.8 1 5 
Total 80 100 20 100 
Range 21-73 26-72 
Mean 45.0 41.8 
SD 13.5 11.7 
‘p’ 
0.3494  
Not Significant 
 
Mean Age in study group were 45.0 with SD of 13.5 years.  Control 
group mean was 41.8 with SD of 11.7 years. ‘p’ value 0.3494. The 
difference was statically not significant. That is the two groups were 
comparable. 
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Table 7  : Sex Distribution 
 
Test  Group Control Group 
Sex 
No % No % 
Male 40 50 9 45 
Female 40 50 11 55 
Total 80 100 20 100 
‘p’ 
0.8807  
Not significant 
 
 
Total no of patients - 100 
Male               - 49 
Female  - 51 
Both sexes were equally distributed in this study and control Groups.  
The ‘p’ value is   (0.8807), statistically not significant. 
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Table 8 : BMI 
 
 Test Group Control Group 
BMI Group 
No % No % 
I (<25) - - 20 100 
II (25 – 26.9) 31 38.8 - - 
III (27 – 29.9) 28 35 - - 
IV (>30) 21 26.3 - - 
Range 25.1-40.3 19.4-24.7 
Mean 28.7 22.3 
SD 3.4 1.6 
‘p’ 
0.0001  
Significant 
 
The mean BMI in Study group were 28.7 with SD of 3.4. Control group 
mean BMI was 22.3 with SD of 1.6.  ‘p’ value 0.0001. The difference 
was statistically significant. 
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Table 9 : BMI and Age  
Age Group 
Upto 30 31 - 40 41-50 51-60 61-70 BMI 
Group 
No % No % No % No % No % 
I (20) 4 20 5 25 5 25 5 25 1 5 
II (31) 7 22.6 7 22.6 6 19.4 5 16.1 6 19.4 
III (28) 3 10.7 8 28.6 7 25 4 14.3 6 21.4 
IV (21) 3 14.3 6 28.6 6 28.6 3 14.3 3 14.3 
Mean BMI 26.3 27.8 28.1 27 27.5 
SD 3.6 4.4 4.5 4.2 2.7 
‘p’ 
0.729 
Not Significant 
 
Total no of patients 100. Mean BMI in age up to 30 years were 26.3 with 
SD of 3.6. Mean BMI in age  group 31- 40  years were 27.8 with SD of 
4.4.  
Mean BMI in age group  41 -50 years were 28.1 with SD of 4.5.  
Mean BMI in age group  51 - 60 years were 27 with SD of 4.2.  
Mean BMI in age group 61 - 70 years were 27.5 with SD of 2.7. 
‘p’ value 0.729. Statistically not significant. 
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Table 10 : BMI and Systolic B.P. 
 
Systolic B.P 
BMI Group 
Mean SD 
I 115.0 16.6 
II  125 18.6 
III  129.3 23.1 
IV  134.9 29.8 
‘p’ 
0.0434 
Significant 
 
 
Mean systolic Blood pressure was composed among the difference 
groups. 
Mean Systolic BP in BMI group I (control group) were 115.0 with SD of 
16.6. 
 Mean Systolic BP was increased from Group I to Group IV, which is 
statistically significant.      ‘p’ value 0.0434. 
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Table 11 : BMI and Diastolic B.P. 
 
Diastolic B.P 
BMI Group 
Mean SD 
I 71.9 11.8 
II 76.3 15.5 
III 79.1 17.3 
IV 84.6 16.5 
‘p’ 
0.0423 
Significant 
 
 
Mean Diastolic Blood pressure is composed among the difference groups. 
Mean Diastolic BP in BMI group I (control group) were 71.9 with SD of 
11.8. 
 Mean Diastolic BP was increased from Group I to Group IV, which is 
statistically significant  ‘p’ value 0.0423. 
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Table 12 .BMI AND HYPERTESION 
 
Hypertension 
Present Absent BMI Group 
No % No % 
I (0) 3 15 17 85 
II (31) 9 29 22 71 
III (28) 8 28.6 20 71.4 
IV (21) 8 38.1 13 61.9 
Mean BMI 29.06 25.01 
SD 4.98 3.4 
‘p’ 
0.03151 
 Significant 
 
Mean BMI among the Hypertensive patients were 29.06 with SD of 4.98 
and Mean BMI among the non  hypertensive patients were 25.01 with SD 
of 3.4. The percentage of Hypertension increased from group I to IV (15 
to 38.1 %). 
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Table 13 : BMI and Lipid Profile 
 
TGL VLDL HDL TC LDL BMI 
Group Mean SD Mean SD Mean SD Mean SD Mean SD 
I (20) 138.2 38 27.6 7.6 54.2 9.1 192.2 27.8 110.4 27.4
II (31) 147.3 36.6 29.5 7.3 49.3 9.3 210.7 27.3 131.9 27.4
III (28) 156.8 41.3 31.4 8.3 48.3 10.5 214.4 27.3 134.8 25 
IV (21) 162.5 40.4 32.5 8.1 44.7 10.1 214 30.4 136.8 26.5
‘p’ 
0.0251 
Significant 
0.0251 
Significant 
0.0208 
Significant 
0.0217 
Significant 
0.0022 
Significant 
 
TC  
 The mean total cholesterol in the control group (I) was 192.2 with 
SD of 27.8. The mean total cholesterol was increased from group I to 
group III. In Group IV there was not much difference in mean TC with 
group III.  ‘p’ value 0.0217. The difference was statistically significant.   
 TGL 
 The mean TGL (triglyceride)  in the control group (I) was 138.2 
with SD of 38. The mean TGL was increased from group I to group IV. 
‘p’ value 0.0251. The difference was statistically significant.    
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VLDL 
 The mean VLDL in the control group (I) was 27.6 with SD of 7.6. 
The mean VLDL was increased from group I to group IV. ‘p’ value 
0.0251. The difference was statistically significant.    
 
 
HDL 
 The mean HDL in the control group (I) was 54.2 with SD of 9.1. 
The mean HDL was decreased from group I to group IV. ‘p’ value 
0.0208. The difference was statistically significant.   
 
 LDL 
 The mean LDL in the control group (I) was 110.4 with SD of 27.4. 
The mean LDL was increased from group I to group IV. ‘p’ value 0.0022. 
The difference was statistically significant.    
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Table 14 : Correlation of BMI and TC / HDL ratio 
 
 
TC / HDL ratio BMI Group 
Mean SD 
I 3.73 1.24 
II  4.47 1.23 
III  4.65 1.21 
IV  5.01 1.32 
‘p’ 
0.0017 
Significant 
 
 
The mean TC/HDL ratio in the control group (I) was 3.73 with SD of 
1.24. The mean TC/HDL ratio is increased from group I to group IV. ‘p’ 
value 0.0017. The difference is statistically significant.    
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Table 15 : BMI and Dyslipidemia 
 
Dyslipidemia 
 
Present Absent BMI Group 
No % No % 
I (20) 4 20 16 80 
II (31) 10 32.3 21 67.7 
III (28) 14 50 14 50 
IV (21) 11 52.4 10 47.6 
Mean BMI 29.13 26.38 
SD 4.48 3.3 
‘p’ 
0.0052 
Significant 
 
Mean BMI in the dyslipidemic patients were 29.13 with SD of 4.48. and 
absents of dyslipidimia patients had mean BMI of 26.38 with SD of 3.3. 
‘p’ value 0.0052. statistically significant dyslipidimia increasing from 
Group I to Group IV. 
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Table 16 : BMI and Fasting B.S 
 
FBS 
BMI Group 
Mean SD 
I (20) 90.8 10.2 
II (31) 96 11 
III (28) 99.5 16.5 
IV (21) 103.4 22.5 
‘p’ 
0.049 
Significant 
 
 
 The mean Fasting Blood sugar in the control group (I) was 90.8 
with SD of 10.2. The mean Fasting Blood sugar was increased from 
group I to group IV. ‘p’ value 0.049. The difference is statistically 
significant.    
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Table 17 : BMI and DM 
DM 
BMI Group 
Present Absent 
I (20) 1 5 19 95 
II (31) 3 9.7 28 90.3 
III (28) 4 14.3 24 85.7 
IV (21) 5 23.8 16 76.2 
Mean BMI 30.22 27.0 
SD 4.2 3.7 
‘p’ 
0.0063 
Significant 
 
Mean BMI in the Diabetic group was  30.22 with SD 4.2   and for Non 
Diabetic group Mean BMI was 27.0 and SD 3.7. ‘p’ value is ( 0.0063) 
,statistically significant. The prevalence of diabetes  increases from 
Group I to Group IV ( 5% to 23.8%) 
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Table 18 : BMI and Smoking ( among males) 
 
Smoking 
Present Absent BMI Group 
Number % Number % 
I (9) 4 44.4 5 55.6 
II (17) 3 17.6 14 82.4 
III (13) 2 15.4 11 84.6 
IV (10) 1 10 9 90 
Mean BMI 25.2 28.1 
SD 3.9 3.8 
‘p’ 
0.0432 
Significant 
 
Mean BMI among smokers were 25.2 with SD of 3.9 and for non 
smokers 28.1 with SD of 3.8. The ‘p’ value is (0.0432),statistically 
significant. 
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Table 19   : Relationship of Waist circumference with Dyslipidemia 
and Hypertension                    
 
Dyslipidemia 
Hypertension Waist 
Circumference 
Present Absent Present Absent 
Mean 90.9 83.5 93.5 83.6 
S.D. 6.2 5.9 5.4 5.5 
‘p’ 
0.0001 
Significant 
0.0001 
Significant 
The  mean waist circumference among dyslipidemic groups were 90.9 
with SD of 6.2 and for non dyslipidemic groups were 83.5   with SD of 
5.9. p’ value 0.0001 statistically significant. 
 The mean  waist circumference among  Hypertensive  groups were 93.5 
with SD of 5.4 and for non  hypertensive  groups were 83.6   with SD of 
5.5. p’ value 0.0001. statistically significant. 
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Table 20  : Relationship of Waist / Hip ratio with Dyslipidemia and 
Hypertension 
 
 
Dyslipidemia 
Hypertension 
Waist / Hip ratio 
Present Absent Present Absent 
Mean 1 0.86 1.05 0.86 
S.D. 0.14 0.06 0.14 0.05 
‘p’ 
0.0001 
Significant 
0.0001 
Significant 
The mean  waist hip ratio  among dyslipidemic groups were  1.0 with SD 
of 0.14 and for non dyslipidemic groups were 0.86   with SD of 0.06. p’ 
value 0.0001,statistically significant. 
 The waist circumference among  hypertensive  groups were 1.05 with 
SD of  0.14 and for non  hypertensive groups were 0.86   with SD of 
0.05.The  p’ value is  (0.0001) statistically significant. 
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Table 21 : Lipid profile and HT 
 
Hypertension 
Present Absent Lipid 
Mean SD Mean SD 
 
‘p’ 
TGL 188.6 36.7 139.1 29.8 
0.0001 
Significant 
VLDL 37.7 7.3 27.8 6.0 
0.0001 
Significant 
HDL 41.1 8.4 50.8 9.2 
0.0001 
Significant 
TC 235.3 28.4 202.7 20.9 
0.0001 
Significant 
LDL 156.5 25.6 124.1 19.2 
0.0001 
Significant 
 
 
In hypertensive patients TGL, TC and LDL is increased and HDL is 
decreased compared to non hypertensive patients. 
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Table 22 : Lipid profile and DM 
 
DM 
Present Absent Lipid 
Mean SD Mean SD 
‘p’ 
TGL 195.3 39.6 148.8 35.9 
0.0029 
Significant 
VLDL 39.1 7.9 29.8 7.2 
0.0029 
Significant 
HDL 40.1 6.7 48.8 9.9 
0.008  
Significant 
TC 225.5 27.6 206.2 18.6 
0.00396  
Significant 
LDL 142.3 29.3 133.0 25.6 
0.3592  
Not Significant 
 
TC, TGL  are significantly elevated in Diabetes patients compared to Non 
diabetic and HDL was decreased in Diabetic patients. Mean  LDL Value 
was not significantly elevated in  Diabetic patients.  
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DISCUSSION AND COMPARATIVE ANALYSIS 
 
Obesity is a chronic and increasingly common health hazard.  
Traditionally, this was believed to be associated with affluent lifestyles in 
the West. However, obesity is a fast growing problem in developing 
countries and is now known to be associated with increased health risks. 
Several studies in India have shown that changes in dietary patterns, 
physical activity levels, life styles associated with affluence, and 
migration to urban areas are related to increasing  risk of metabolic 
diseases such as type 2 diabetes mellitus, hypertension and dyslipidaemia 
. 
                        The most widely used method to gauge obesity is the  
Body mass index (BMI) criteria are  focus in obesity treatment 
recommendations,with different treatment cutoff points based up on the 
presence or absence of obesity-related comorbid disease .In addition, 
many patients with these metabolic diseases are either overweight or 
obese.  Important relationship between BMI and metabolic metabolic 
disease is critical toward a better understanding  of the underlying 
pathophysiological processes leading to excessive fat-related metabolic  
disease. 
 In this study  100 patients were included according to the inclusion 
and exclusion criteria. Among hundred patients, 80 Patients (40 Males 
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and 40 Females) whose BMI was ≥ 25 formed the Study Group who were 
divided into 3 Groups, according to BMI.  
 
 
        Group                  BMI   
            II                   ≥ 25 – 26.9 
           III                   ≥27 – 29.9 
            IV                   ≥30 
 
 Control Group consisted of age matched 20 Patients (9 males and 
11 Females) with BMI < 25 and designated   as Group I.  
Anthropometric results 
 The mean BMI in this  Study group is  28.7. Control group mean 
BMI is 22.3. 
 According to Indian standards   for BMI   values (Classification of 
Overweight and obesity by Body mass index), BMI of our study group 
belongs to obesity class I (28.0-32.9) 
The Nutrition Foundation of India (NFI) study showed that 32.3% of 
middle class males and 50% of middle class females in Delhi are obese.4  
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According to H. E. Bays  et al  (2007): The  National Health And 
Nutrition Examination Surveys (NHANES) showed mean BMI  was 27.9 
compared to 28.9 in this study  and  “ The Study To  Help Improve Early 
Evaluation and Management of Risk Factors Leading to Diabetes 
(SHIELD) Survey”  mean BMI was 27.8 . 
 In both studies Prevalence of diabetes mellitus, hypertension, and 
dyslipidemia occurred among all obese subjects, but   the prevalence 
correlated with increase in BMI54. 
Study by H Shukla et al (2002) – In this study (cross- sectional) 
representative surveys were carried out in the city of Mumbai in Western 
India. Results showed 19% of men and women were thin built 
(BMI<18.5 kg/m2), while 19% of men and 30% of women were 
overweight (BMI≥25kg/m2)55. 
Pragti Chhabra, Sunil K. Chhabra et al - In their study, overall only 
half (49.7%) of the subjects had a normal nutritional status, while 24.8% 
were underweight, 19.4% overweight, and 6.1%. obese56. 
Ron T Varghese, Vijayakumar K  et al - In their study of pattern of 
obesity across different age groups in a rural setting   showed that  30-40 
% of the population  was either obese or overweight57. 
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 BMI and Smoking ( among males) . 
 In our study  mean BMI among smokers were  lower  (25.2 ) than  
the non smokers (28.1) . According to Mangesh S ,Pednekar et al(2006) 
in their study “Association between tobacco use and body mass index in 
urban Indian population: implications for public health in India” ,  
showed that  all forms of tobacco use were associated with low BMI. The 
prevalence of low BMI was highest in bidi-smokers (32% compared to 
13% in non-users) 58 
 
HYPERTENSION IN OBESITY 
  In this study parameters like hypertension (Systolic& Diastolic 
B.P), was analysed among all BMI groups. 
 
BMI and systolic B.P 
 Mean systolic Blood pressure on comparison  showed 115.0 mm 
Hg in group I   while in  group  II,  III and  IV  it was 125, 129.3 and  
134.9 respectively.  Mean Systolic BP increased from Group I to Group 
IV. 
 
BMI and Diastolic B.P 
 Mean Diastolic Blood pressure was compared  among the different 
groups Mean Diastolic BP in BMI group I (control group) is  71.9  while 
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in  group  II,  III and  IV  it was 76.3 , 79.1  and 84.6 respectively. Mean 
Diastolic BP increased from Group I to Group IV.         
                             
Brown et al study - four categories of BMI (<25, 25≤27, 27 ≤30, and 
≥30) were compared for hypertension and Dyslipidemia. The results 
showed that mean systolic and diastolic blood pressures increased with 
increasing BMI in men and women. Systolic blood pressure increased 
from 121.3 to 130.7 mm Hg in males and 115.7 to 127.3 mm Hg in 
women according to low BMI to high BMI group. Similarly, Diastolic BP 
also increased from 74.0 to 80.9 mm Hg in males and 69.7 to 76.0mmHg 
in women according to low BMI to high BMI group32. Our study results 
are similar to this study. 
 Among men the prevalence of high blood pressure increased 
progressively with increasing BMI from 15% at a BMI of <25 to 42%  
with BMI of ≥30 .Prevalence of high blood pressure increased 
progressively from 15% among women with BMI of <25 to 38% among 
women with BMI of >30.33 
 In NHANES III, the age-adjusted prevalence of hypertension 
(defined as systolic blood pressure >140 mm Hg, diastolic blood pressure 
>90 mm Hg, or use of antihypertensive medication) in obese men and 
women was 42% and 38%, respectively. These prevalence rates are more 
than twice of the prevalence of hypertension in lean men and women 
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(15% prevalence rate in both men and women)59, 60 . The risk of 
hypertension also increases with weight gain . 
 Among subjects followed in the Framingham Study, there was a.6.5-
mm Hg increase in blood pressure with every 10% increase in body 
weight. 33 
 
Weight gain, even to levels not considered to be a problem, increases the 
incidence of hypertension. This was clearly shown in a Nurses' Health 
Study (Huang et al., 1998)  .Those women, now in midlife, who had 
gained as little as 5 kg over their weight at age 18 had a 60% higher 
relative risk of developing hypertension than did those whose weight had 
not changed more than 2 kg.16 
 
 According to H. E. Bays et al   SHIELD study showed that 80% of 
hypertensive patients were overweight or obese54. 
 
 Diabetes correlation with BMI 
 Mean BMI in the Diabetic subjects  were  30.22 compared to the 
non Diabetic whose Mean BMI was 27. The ‘p’ value (0.0063 was 
statistically significant. The prevalence of diabetes   on comparison  
showed  5 % in group I   while in  group  II,  III and  IV  it was 9.7 , 14.3 
and  23.8 respectively .                                                                   
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The prevalence of diabetes   increases from  lowest  BMI Group I to 
Highest BMI Group IV (5% to 23.8%).  
Harris et al  study showed that (NHANES III), two thirds of the men 
and women in the United States with diagnosed type 2 diabetes have a 
BMI of 27.0 kg/m2 or greater.27 
Flegal KM et al in their study,  the risk of diabetes increases linearly 
with BMI: the prevalence of diabetes increased from 2% in those with a 
BMI of 25.0 to 29.9 kg/m2, to 8% in those with a BMI of 30 to 34.9 
kg/m2, and to 13% in those with a BMI greater than 35 kg/m2.  3 
In the “Nurses' Health Study”, the risk of diabetes began to increase 
when BMI exceeded the “normal” value of 22 kg/m2 . 
 Ohlson L.O et al, Lundgren. H et al  and . Kaye et al  in their  studies 
showed that  the risk of diabetes also increases with weight gain during 
adulthood. Among men and women aged 35 to 60 years, the risk of 
diabetes was three times greater in those who gained 5 to 10 kg since the 
age of 18 to 20 years than in those who maintained their weight within 2 
kg. 28,29,30.       
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Lipid profile in correlation with BMI  
       
 TC  
  In this  study the mean total cholesterol in the control group (I) was 
192.2 . The mean total cholesterol was increased from group I to group 
IV .  
 Brown et al . reported  that mean serum cholesterol level increased with 
increasing BMI from 193mg/dl among men at the lowest  BMI category 
to 211mg/dl in men at the highest BMI category .Among women TC 
levels increased from 195mg/dl to 217mg/dl.32  
In our study the TC in males among  group I  was 189.2 and 209.3 
in(highest BMI) group IV. Mean total cholesterol increased  from Group I 
to Group IV in males.  
 
 In women TC  in  group I  was 194.7  and 218.6 in group III  and 218.3 
in group IV .  In  females Mean total cholesterol increased  from Group I 
to Group III and plateaued at Group I V . 
 
This is comparable  to Brown et al  that, in men, there was a progressive 
increase in the prevalence of hypercholesterolemia (total blood 
cholesterol >240 mg dL or 6.21 mmol/L) with increasing BMI. In 
women, by contrast, the prevalence of hypercholesterolemia was highest 
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at a BMI of 25.0 to 27.0 kg/m2, and it did not increase further at higher 
BMI values.  
 
Hanumanthappa Nandeesha, et al in their study  total cholesterol, 
triglyceride and LDL cholesterol were found to be significantly increased 
in overweight and obese subjects and HDL cholesterol was significantly 
decreased in obese subjects59. 
HDL 
 The mean HDL in the control group (I) was 54.2 with SD of 9.1. 
The mean HDL decreased from group I to group IV.  
 Brown  et al in their  study showed that mean HDL WITH BMI <25 
WAS 50mg/dl and it declined to 40mg/dl at a BMI of ≥30 .Among 
women the age adjusted mean HDL level decreased from 50mg/dl with 
BMI of <25 to 49mg/dl for women with BMI of ≥30. 
In our study also showed that mean HDL in group I (BMI <25 ) was 54.2 
with SD 9.1 in group IV(≥30) mean HDL was 44.7 with SD of 10.1 HDL   
progressively decreased from group I to group IV. 
 
 Dongsheng Hu  et al  in  their Strong Heart Study there was a 60% 
increase in BMI (from 25 to 40 kg/m2) was associated with a  6-mg/dL 
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decrease in HDL cholesterol in women,and  12-mg/dL decrease in HDL 
cholesterol in men .60 
 The main lipoprotein abnormality related to obesity in American Indians 
was decreased HDL cholesterol, especially in men. Central adiposity was 
more associated with abnormal lipid/lipoprotein profiles than general 
obesity in women; both were equally important in men. 
Bhatti MS et al 2001 , in their  study regarding lipid profile in obesity 
showed that obese persons total lipids, total cholesterol, , LDL, VLDL, 
chylomicrons LDL/HDL, VLDL/HDL, TG/HDL and TC/HDL ratios 
level showed significant increase while HDL level was significantly 
decreased.61 
 
TGL 
The mean TGL (triglyceride)  in the control group (I) was 138.2 with SD 
of 38. The mean TGL was increased from group I to group IV.  
Domenico Sommariva et al  in their  study  showed  that body mass 
index is positively correlated with serum triglycerides, VLDL lipids, 
HDL-triglycerides are* negatively correlated with HDL-cholesterol.62 
In the Strong Heart Study population , by  Dongsheng Hu  et al   
showed that 60% increase in BMI (from 25 to 40 kg/m2) was associated 
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with a 5-mg/dL increase in triglyceride in women and but a 74-mg/dL 
increase in triglycerides in men.60 
 Bhatti MS et al  in their study regarding lipid profile in obesity noticed 
that Direct correlation between plasma triglycerides and body weight 61. 
LDL 
The mean LDL in the control group (I) was 110.4 with SD of 27.4. The 
mean LDL was increased from group I to group IV. 
 
Misra A. et al : “Prevalence of diabetes, obesity and dyslipidaemia in 
urban slum population in northern India” among 532 subjects (170 males 
and 362 females)  showed that  total cholesterol and low-density 
lipoprotein cholesterol were high in both males and females.63 
Ronald M. Krauss, et al ,in their study  “Obesity -Impact on 
Cardiovascular Disease” showed that obesity has a strong effect on 
lipoprotein metabolism, regardless of ethnic group. Increased weight is a 
determinant of higher levels of triglycerides, elevated LDL-C, and low 
HDL-C.. The association between obesity and LDL-C is more complex. 
LDL-C concentrations increase with BMI in men, but such increases are 
not as pronounced in women, the elderly, and some ethnic groups. 
Increasing BMI is associated with small, atherogenic LDL. Furthermore, 
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central obesity in women is associated with elevated LDL-C 
concentrations.64 
TC/HDL ratio. 
 The mean TC/HDL ratio in the control group (I) was 3.73 with SD 
of 1.24. In Group IV it was 5.01 with SD of 1.32. The mean TC/HDL 
ratio was increased from group I to group IV. ‘p’ value 0.0017. The 
difference was statistically significant.    
Jean-Pierre et al in their study “ Evaluation and management of 
atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol”  
Study shows that  elevation of the total cholesterol  to HDL-C  ratio in the 
absence of marked elevation of LDL-C level is a salient feature of 
insulin-resistance ,  among abdominal obesity patients, as well as of type 
2 diabetic patients.Among men there was a high prevalence of the 
metabolic syndrome ( 40%). 
BMI and Dyslipidemia 
Mean BMI in the dyslipidemic patients  were s  26.38 with SD of 3.3.The  
‘p’ value( 0.0052.)is statistically significant.  Dyslipidemia  showed 
increasing pattern from Group I to Group IV. (20 % to 52.4 %) . 
In  NHANES STUDY   84% of dyslipidaemic patients were overweight  
or obese54.In  SHIELD STUDY  75% of  dyslipidaemic  patients were  
overweight  or   obese SHIELD and NHANES demonstrated  that a 
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gradual increases in dyslipidaemia is seen with  progression of BMI till  
30 kg/m2 . Beyond BMI of 30 kg/m2   prevalence plataued and in fact 
estimates began to decline in NHANES. 54 
 
Waist circumference correlation with  Dyslipidemia and 
Hypertension  
The  mean waist circumference among dyslipidemic groups were 90.9 
and for non dyslipidemic groups were 83.5  .The  p’ value( 0.0001) is 
statistically significant in our study. 
 The mean  waist circumference among  hypertensive  groups were 93.5 
and 83.6 for non hypertensive groups .The  p’ value (0.0001) statistically 
significant in our study.  
Okosun et al,1998  study showed that  Waist circumference was 
positively correlated with blood pressure and fasting blood glucose. 
Substantial reduction in hypertension and diabetes in men and women is 
achievable if the waist size is decreased in these populations.67 
Ian Janssen et al  2004.,study showed that the addition of waist 
circumference (WC) to body mass index (BMI; in kg/m2) predicts a 
greater variance in health risk than does BMI alone.67 
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Waist  Hip ratio with Dyslipidemia and Hypertension 
 The mean  waist hip ratio  among dyslipidemic groups were  1.0  and for 
non dyslipidemic groups were 0.86   .The  p’ value is  statistically 
significant. 
 The waist circumference among  hypertensive  groups were 1.05  and for 
non  hypertensive groups were 0.86  . The p’ value  is statistically 
significant.  
  
Yusuf S et al study, 2005  showed that  waist-to-hip ratio of  more than 
0.83 for women and 0.9 for men would result in a 3-fold increase in 
population attributable risk for myocardial infarction. This is particularly 
important in regions such as Asia, which have not had significant 
problems with obesity as measured by BMI but would have considerably 
greater cardiovascular risk if waist-to-hip ratio was used.68 
Jern et al, 1992 study .The aims were to investigate the influence of 
obesity (as defined by body mass index) and abdominal fat accumulation 
(as defined by the waist/hip ratio) on hemodynamics at rest and during 
mental stress. Cardiac output and stroke volume were positively 
correlated to body mass index, but inversely to waist/hip ratio).Total 
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peripheral resistance during stress correlated inversely to body mass 
index whereas high waist/hip ratio was associated with higher systemic 
vascular resistance .69 
 
Lipid profile abnormalities in  Hypertension 
In this study  TC ,TGL,  LDL and TC:HDL ratio  were increased and  
HDL level were decreased  among   the  hypertensive subjects*  
compared to the  non  hypertensive subjects.  
 
Our study  was  supported by the  Thakur AK et al  ‘ Study  of lipid  
level in uncomplicated Hypertension’.   In their  study mean total 
cholesterol   and  TC:HDL ratio  were  higher among  hypertensives.70  
 
Ruben O. Halperin et al in their study “ Dyslipidemia and the Risk of 
Incident Hypertension in Men demonstrated higher levels of plasma TC, 
non-HDL-C, and the TC/HDL-C ratio are independently associated with a 
subsequent increased risk of incident hypertension in apparently healthy 
men and that higher levels of HDL-C are associated with a decreased risk 
of incident hypertension.71 
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Lipid profile in Diabetic patients. 
 
TC, TGL  are significantly elevated in Diabetes patients compared to non 
diabetic and HDL was decreased in Diabetic patients. Mean  LDL Value 
was not significantly elevated in  Diabetic patients. 
 
H.B. Chandalia et al  in their study “   LIPID ABNORMALITIES IN 
DIABETES MELLITUS”    reported   that Plasma cholesterol and 
triglycerides were significantly elevated in diabetics compared to  non-
diabetics. Reduction of HDL cholesterol (by 10-20%), primarily due to a 
fall of HDL cholesterol is also seen. 
The most frequent serum lipid abnormality in Type2 diabetes is an 
elevation of serum triglycerides to 1.5 - 3.0 times non-diabetic controls.72  
Jim Nuovo et al  demonstrated  hyperlipidemia in patients with Type 2 
Diabetes in their study . The most common lipid abnormalities in these 
patients include hypertriglyceridemia and reduced high-density 
lipoprotein (HDL) cholesterol levels.73  
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                               CONCLUSION 
 
 
• The prevalence of high blood pressure and mean levels of 
systolic and diastolic blood pressure are increased among 
increased  BMI groups.  
 
• As BMI increases   total cholesterol, LDL,TGL, TC/HDL 
ratio increases and  HDL decreases. 
 
• Dyslipidemia is more common among obese patients 
compared to patients with normal body mass index. 
 
 
• In general, the presence of hypertension, high total 
cholesterol, LDL,  TGL, TC/HDL ratio and low HDL  shows 
increasing trend with  increasing BMI, as does the combined 
prevalence of both hypertension and dyslipidemia 
• The prevalence of diabetes is increased as the BMI increases 
 
 
72 
 
 
SUMMARY 
The study “DYSLIPIDEMIA AND HYPERTENSION IN OBESE PATIENTS WITH 
CORRELATION TO BODY MASS INDEX” is a  cross- sectional  study among  
patients attending medical Outpatient  Department and  Medical Wards   
in Govt Rajaji Hospital for varying illness , 80 Patients  ( 40 Males and 
40 Females )  whose BMI  were  ≥ 25  selected for  the  study 
Group(Group II ,III ,IV ) and 20 Patients ( 9 males and 11 Females)   
whose BMI  < 25  were selected   in  the same age group as controls 
(Group I). 
 
Subjects divided into four groups according to BMI  
        Group                BMI   
            I                    25                Healthy weight 
           II                   ≥ 25 – 26.9     Overweight 
           III                   ≥27 – 29.9     Overweight 
            IV                  ≥30               Obesity  
 
Patients and controls who satisfied the inclusion and exclusion criteria 
underwent various investigations like fasting  blood sugar, and  lipid 
profile were taken. Relationship of various anthropometric measurements 
like body mass index ,waist circumference, waist hip ratio  were 
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analyzed. A high BMI  showed  significant correlation with hypertension, 
diabetes and dyslipidemia. 
 Thus our study highlights the significance of a simple measurement 
of  BMI in day to day clinical practice in detecting the patients with high 
cardiovascular risk like hypertension, diabetes, obesity, dyslipidemia and 
metabolic syndrome. The cut off values for and BMI,  waist 
circumference, and waist hip ratio should be defined according to the 
different ethnic populations. This will help in early detection of the 
people at risk so that we can advice healthy life style and nutritional 
habits for the high risk group and start specific therapy when ever 
necessary. 
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APPENDIX-2 
 
GLOSSARY 
 
 
BMI     - Body Mass Index 
 
BP     - Blood Pressure 
 
CAD     - Coronary Artery Disease 
 
CHD     - Coronary Heart Disease 
 
CM     - Chylomicrone 
 
CRP     - C Reactive Protein 
 
CVD     - Cardio Vascular Disease 
 
DM     - Diabetes Mellitus 
 
DBP     - Diastolic Blood Pressure 
 
ECG     - Electro Cardiogram 
 
EF     - Ejection Fraction 
 
F/H     - Family History 
 
HT     - Hypertension 
 
HDL     - High Density Lipoprotein 
 
HC     - Hip Circumference 
 
IR     - Insulin Resistance 
 
LDL     - Low Density Lipoprotein 
 
Lp (a)     - Lipoprotein (a) 
 
MS     - Metabolic Syndrome 
 
 
 
NCEP- ATP III - National Cholesterol Education 
Programme. 
   Adult Treatment Panel – III 
 
IDF - International Diabetic Federation 
 
OCP - Oral Contraceptive Pill 
 
SBP - Systolic Blood Pressure 
 
TC - Total Cholesterol  
 
TG - Triglyceride 
 
VLDL - Very Low Density Lipoprotein 
 
WC - Waist Circumference 
 
WHO - World Health Organisation  
 
WHR - Waist Hip Ratio 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDEX-3 
 
PROFORMA 
 
DYSLIPIDEMIA AND HYPERTENSION IN OBESE PATIENTS 
WITH CORRELATION TO BODY MASS INDEX 
 
1.  Sl. No           : 
2.  Name   : 
3.  IP/OP No   : 
4.  Age    : 
5.  Domicile   : Urban/Rural 
6.  Life Style   : Sedentary / Non Sedentary 
7.  Diet    : Vegetarian / Non Veg. 
8.   Smoking       : present /Absent. 
9. Past History  : HT / DM / CVA / CAD / Others 
10. Drug History  : OCP/ Steroids / Beta blocker/ 
Frusemide / Others 
11. Examination   : Anthropometry 
 
 
 
 
 
Height  
(in cm) 
Weight  
(in kgs) 
BMI  
Kg/m2  
Waist (in cm) 
Circumference
Hip (in cm) 
Circumference 
W /H 
Ratio 
      
 
G.E   : Pallar / Edema / Cyanosis / Jaundice / Clubbing 
 
CVS   :  PR   :    BP   :   JVP    :  
     
S1    S2                  S3               S4 
 
RS   :  
 
Abdomen  : 
 
 
17. Investigation : 
 
FBS 
 
Fasting lipid profile 
 
Total 
Cholesterol 
T.G HDL VLDL LDL 
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MASTER CHART 
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1 29 Male Control 1 163 55 20.7 75.0 86.2 0.87 2 102 70 2 89 131 26 60 196 110 3.27 
2 29 Female Control 2 148 50 22.8 73.0 92.4 0.79 2 100 60 2 86 122 24 65 195 106 3.01 
3 41 Female Control 2 145 43 20.5 77.0 100.0 0.77 2 114 64 2 82 116 23 65 185 97 2.85 
4 38 male Control 1 156 53 21.8 81.0 89.0 0.91 2 118 64 2 85 121 24 50 188 114 3.76 
5 52 Male Control 1 162 51 19.4 84.0 98.8 0.85 2 112 72 2 87 121 24 47 181 110 3.86 
6 42 Female Control 2 148 54 24.7 88.0 91.7 0.96 2 114 66 2 130 220 44 38 224 142 5.89 
7 34 Female Control 2 146 42 19.7 74.0 91.4 0.81 2 100 64 2 86 115 23 60 167 84 2.78 
8 37 Female Control 2 156 52 21.4 75.0 98.7 0.76 2 102 60 2 88 120 24 66 184 94 2.79 
9 72 Male Control 2 161 58 22.4 82.0 98.8 0.83 2 130 80 2 92 115 23 51 162 88 3.18 
10 41 Female Control 2 152 57 24.7 71.0 87.7 0.81 2 100 68 2 90 119 24 60 166 82 2.76 
11 45 Female Control 2 154 53 22.3 87.0 95.6 0.91 1 150 96 2 96 189 38 48 256 170 5.33 
12 56 Male Control 1 160 62 24.2 76.0 85.4 0.89 2 124 84 2 88 121 24 50 183 109 3.66 
13 43 Male Control 2 158 59 23.6 85.0 96.6 0.88 2 120 76 2 94 115 23 53 181 105 3.42 
14 51 Male Control 2 158 60 24.0 92.0 83.6 1.10 1 150 96 2 99 210 42 38 248 168 6.53 
15 27 Female Control 2 151 47 20.6 76.0 92.7 0.82 2 98 60 2 84 117 23 58 170 89 2.94 
16 53 Female Control 2 150 52 23.1 79.0 108.2 0.73 2 108 66 2 86 118 24 63 170 83 2.70 
17 53 Female Control 2 155 54 22.5 88.0 94.6 0.93 2 140 92 2 91 224 45 38 241 158 6.34 
18 33 Male Control 2 162 63 24.0 87.0 107.4 0.81 2 100 70 2 87 129 26 58 190 106 3.27 
19 26 Male Control 2 152 49 21.2 78.0 91.8 0.85 2 108 60 2 83 119 24 52 173 97 3.33 
20 33 Female Control 2 148 51 23.3 80.0 102.6 0.78 2 106 70 2 93 121 24 63 183 96 2.91 
21 50 Female T 2 152 82 35.5 97.0 81.5 1.19 2 158 102 2 117 225 45 35 197 117 5.63 
22 29 Female T 2 157 79 32.0 86.0 96.6 0.89 2 114 70 2 88 125 25 50 222 147 4.44 
23 55 Male T 2 153 63 26.9 84.0 89.4 0.94 2 122 64 2 81 170 34 46 180 100 3.91 
 
 
24 66 Female T 2 151 62 27.2 90.0 107.1 0.84 2 128 72 2 98 126 25 66 207 116 3.14 
25 39 Male T 2 160 70 27.3 91.0 100.0 0.91 2 122 72 2 118 124 25 50 186 111 3.72 
26 38 Female T 2 148 60 27.4 82.0 94.3 0.87 2 112 64 2 130 240 48 39 203 116 5.21 
27 29 Male T 1 158 64 25.6 84.0 100.0 0.84 2 110 72 2 94 109 22 50 196 124 3.92 
28 22 Male T 2 157 64 26.0 83.0 96.5 0.86 2 122 60 2 98 136 27 44 200 129 4.55 
29 38 Male T 2 150 67 29.8 82.0 92.1 0.89 2 116 66 2 128 235 47 36 201 118 5.58 
30 45 Male T 1 147 60 27.8 95.0 95.0 1.00 1 166 98 2 89 135 27 50 242 165 4.84 
31 38 Male T 2 149 61 27.5 86.0 98.9 0.87 2 110 64 2 95 130 26 58 212 128 3.66 
32 43 Male T 2 149 64 28.8 90.0 96.8 0.93 2 130 86 2 88 131 26 45 190 119 4.23 
33 28 Female T 2 149 72 32.4 92.0 100.0 0.92 2 102 64 2 86 150 30 34 229 165 6.74 
34 73 Male T 2 150 75 33.3 89.0 86.4 1.03 2 128 88 2 93 135 27 43 180 110 4.19 
35 46 Male T 2 160 71 27.7 86.0 95.6 0.90 2 112 74 2 90 141 28 53 221 140 4.17 
36 25 Male T 2 156 64 26.3 85.0 109.0 0.78 2 112 72 2 102 120 24 50 170 96 3.40 
37 47 Female T 2 163 74 27.9 85.0 97.7 0.87 2 116 62 2 93 115 23 65 205 117 3.15 
38 33 Female T 2 141 58 29.2 86.0 98.9 0.87 2 108 64 2 94 140 28 52 242 162 4.65 
39 44 Female T 2 157 75 30.4 88.0 95.7 0.92 2 116 66 2 89 120 24 66 205 115 3.11 
40 37 Female T 2 145 84 40.0 97.0 93.3 1.04 2 192 110 1 140 210 42 37 250 171 6.76 
41 63 Male T 2 159 67 26.5 80.0 87.9 0.91 2 122 74 2 105 130 26 60 172 86 2.87 
42 46 Female T 2 145 53 25.2 87.0 107.4 0.81 2 116 64 2 83 120 24 66 183 93 2.77 
43 38 Female T 2 151 58 25.4 88.0 101.1 0.87 2 114 60 2 89 111 22 60 216 134 3.60 
44 51 Male T 2 151 60 26.3 88.0 94.6 0.93 2 118 78 2 97 121 24 49 175 102 3.58 
45 42 Male T 2 150 60 26.7 93.0 95.9 0.97 1 154 92 1 128 210 42 38 250 170 6.58 
46 44 Female T 2 147 61 28.2 92.0 98.9 0.93 2 146 98 1 139 205 41 36 183 106 5.08 
47 43 Female T 2 140 72 36.7 99.0 92.5 1.07 1 176 106 2 86 215 43 42 265 180 6.31 
48 50 Male T 2 144 65 31.3 91.0 97.8 0.93 2 112 68 2 95 125 25 60 210 125 3.50 
49 47 Female T 2 146 60 28.1 91.0 100.0 0.91 2 152 102 2 90 130 26 38 181 117 4.76 
50 60 Male T 2 162 70 26.7 84.0 98.8 0.85 2 124 68 2 89 146 29 48 212 135 4.42 
51 61 Male T 1 156 61 25.1 95.0 73.1 1.30 2 148 98 2 111 115 23 37 232 172 6.27 
52 35 Female T 2 152 63 27.3 84.0 98.8 0.85 2 118 66 2 92 115 23 60 208 125 3.47 
53 67 Female T 2 143 53 25.9 89.0 90.8 0.98 2 158 100 2 104 153 31 38 241 172 6.33 
54 65 Female T 2 148 60 27.4 81.0 97.6 0.83 2 106 66 2 90 120 24 60 234 150 3.90 
 
 
55 27 Female T 2 159 76 30.1 96.0 105.5 0.91 2 104 74 2 80 130 26 60 209 123 3.48 
56 34 Male T 1 152 75 32.5 102.0 72.9 1.40 2 146 96 2 90 210 42 32 194 120 6.06 
57 49 Male T 2 159 102 40.3 96.0 100.0 0.96 2 196 104 2 85 220 44 40 256 172 6.40 
58 39 Male T 2 155 68 28.3 81.0 97.6 0.83 2 118 82 2 90 149 30 42 178 106 4.23 
59 36 Male T 2 164 77 28.6 84.0 86.6 0.97 2 122 70 2 92 120 24 48 179 107 3.73 
60 55 Male T 2 150 69 30.7 96.0 105.5 0.91 2 132 84 2 94 125 25 46 173 102 3.76 
61 33 Female T 2 145 68 32.3 98.0 99.0 0.99 2 150 100 2 89 166 33 58 223 132 3.84 
62 33 Female T 2 145 76 36.1 91.0 104.6 0.87 2 106 76 2 145 210 42 58 250 150 4.31 
63 56 Female T 2 144 60 28.9 79.0 96.3 0.82 2 114 66 2 91 125 25 38 210 147 5.53 
64 67 Male T 2 153 68 29.0 81.0 85.3 0.95 2 134 62 2 89 214 43 34 204 127 5.99 
65 29 Female T 2 152 69 29.9 83.0 100.0 0.83 2 102 62 2 97 121 24 55 216 137 3.93 
66 55 Male T 2 158 92 36.9 100.0 95.2 1.05 1 170 110 1 135 161 32 42 244 170 5.81 
67 43 Male T 2 153 74 31.6 91.0 94.8 0.96 2 116 72 2 88 144 29 42 184 113 4.38 
68 51 Male T 2 162 90 34.3 103.0 86.6 1.19 2 158 100 2 110 215 43 32 257 182 8.03 
69 71 Male T 2 159 65 25.7 96.0 87.3 1.10 1 164 102 2 104 210 42 50 256 164 5.12 
70 37 Male T 2 150 58 25.8 87.0 107.4 0.81 2 122 70 2 84 135 27 45 181 109 4.02 
71 25 Female T 2 159 67 26.5 78.0 94.0 0.83 2 102 62 2 82 145 29 54 241 158 4.46 
72 37 Female T 2 155 64 26.6 84.0 98.8 0.85 2 120 62 2 130 205 41 37 232 154 6.27 
73 34 Female T 2 148 59 26.9 74.0 89.2 0.83 2 110 72 2 87 110 22 62 174 90 2.81 
74 55 Male T 2 150 61 27.1 98.0 86.0 1.14 2 174 106 2 105 210 42 30 236 164 7.87 
75 51 Female T 2 144 57 27.5 80.0 93.0 0.86 2 122 68 2 106 145 29 58 181 94 3.12 
76 72 Female T 2 146 60 28.1 93.0 82.3 1.13 1 164 108 2 91 210 42 60 268 166 4.47 
77 29 Male T 2 154 67 28.3 85.0 100.0 0.85 2 118 68 2 93 140 28 41 194 125 4.73 
78 63 Male T 2 157 78 31.6 90.0 98.9 0.91 2 116 70 2 88 145 29 41 188 118 4.59 
79 36 Male T 2 150 73 32.4 87.0 100.0 0.87 2 108 72 2 146 151 30 42 207 135 4.93 
80 62 Male T 2 163 70 26.3 79.0 89.8 0.88 2 122 68 2 86 145 29 45 206 132 4.58 
81 55 Male T 2 156 65 26.7 76.0 85.4 0.89 2 112 84 2 99 129 26 50 208 132 4.16 
82 50 Female T 2 152 62 26.8 76.0 96.2 0.79 2 116 64 2 85 130 26 60 201 115 3.35 
83 65 Female T 2 150 61 27.1 92.0 93.9 0.98 1 164 104 2 100 210 42 36 262 184 7.28 
84 29 Male T 2 154 65 27.4 91.0 107.1 0.85 2 102 88 2 83 165 33 48 206 125 4.29 
85 61 Female T 2 152 64 27.7 86.0 97.7 0.88 2 110 64 2 86 160 32 60 244 152 4.07 
 
 
86 68 Female T 2 142 52 25.8 83.0 102.5 0.81 2 124 82 2 94 120 24 62 187 101 3.02 
87 21 Male T 2 156 61 25.1 89.0 102.3 0.87 2 110 64 2 79 130 26 48 200 126 4.17 
88 45 Female T 2 134 46 25.6 87.0 91.6 0.95 1 160 102 2 134 220 44 52 262 166 5.04 
89 53 Male T 1 161 73 28.2 97.0 72.4 1.34 1 162 114 1 143 215 43 38 261 180 6.87 
90 65 Female T 2 153 73 31.2 87.0 102.4 0.85 2 112 64 2 94 115 23 44 186 119 4.23 
91 27 Female T 2 142 52 25.8 80.0 95.2 0.84 2 100 58 2 85 121 24 62 211 125 3.41 
92 42 Male T 2 151 61 26.8 82.0 91.1 0.90 2 110 70 2 86 135 27 48 218 143 4.54 
93 43 Female T 2 148 60 27.4 94.0 93.1 1.01 2 172 98 2 86 120 24 55 249 170 4.53 
94 38 Female T 2 142 61 30.3 90.0 98.9 0.91 2 120 80 2 133 116 23 35 165 107 4.72 
95 40 Female T 2 152 60 26.0 88.0 80.0 1.10 2 142 98 2 102 200 40 35 245 170 7.00 
96 25 Female T 2 150 60 26.7 83.0 101.2 0.82 2 106 60 2 89 130 26 55 231 150 4.20 
97 33 Female T 2 141 53 26.7 86.0 100.0 0.86 2 146 94 2 92 210 42 36 182 104 5.06 
98 51 Male T 1 164 71 26.4 93.0 96.9 0.96 1 158 108 2 100 210 42 35 245 168 7.00 
99 31 Female T 2 156 64 26.3 79.0 100.0 0.79 2 110 60 2 82 109 22 62 223 139 3.59 
100 42 Male T 2 170 76 26.3 79.0 101.3 0.78 2 122 82 2 95 130 26 45 201 130 4.47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                 KEYS TO MASTER CHART 
 
 
                  Smoking  
1- smoker 
2- non smoker 
 
BMI- Body mass index 
WC – Waist Circumference in cms 
HC-     Hip Circumference 
W/H-Waist Hip ratio 
HT- Hypertension 
1- Present 
2- Absent 
SBP- Systolic Blood Pressure 
DBP-Diastolic Blood Pressure 
DM-  Diabetes Mellitus 
1- Present 
2- Absent  
FBS-  Fasting Blood Sugar 
 
 
                  HDL- High Density Lipoprotein 
TGL   - Triglycerides 
VLDL  – Very Low Density Lipoprotein 
LDL   -    Low Density Lipoprotein 
TC- Total Cholesterol 
TC/HDL – Total Cholesterol/ High Density 
Lipoprotein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
 
FIG:2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
13
21
19
12
15
4
5
5
5
1
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
TEST
GROUP
CONTROL
GROUP
Upto 30 31-40 41-50 51-60 Above 60
AGE DISTRIBUTION 
 
 
 
 
 
SEX DISTRIBUTION 
 
 
 
FIG:3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 40
9 11
0% 20% 40% 60% 80% 100%
TE
ST
G
R
O
U
P
C
O
N
TR
O
L
G
R
O
U
P
MALES FEMALES
 
 
 
 
 
 
 
 
BMI & LIPID PROFILE 
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 BMI & BLOOD PRESSURE 
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BMI & TC/HDL RATIO 
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BMI & FASTING BLOOD SUGAR 
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BMI & SMOKING 
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BMI & DYSLIPIDEMIA 
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LIPID PROFILE & HT 
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                                               Etiology of Obesity 
 
FIG:1 
 
 
 
 
 
 
 
 
 
 
 
CORRELATION OF 
WAIST /HIP RATIO  WITH 
DYSLIPIDEMIA AND HYPERTENSION 
Fig :12 
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CORRELATION OF 
WAIST CIRCUMFERENCE  WITH 
DYSLIPIDEMIA AND HYPERTENSION 
 
Fig : 11 
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